Another slow bleed week ahead!Hello all, hope you had a good weekend. Looks like more of the same this week... a continued slow bleed.
I think SONA has one last chance; they need some decent sales figures in a well-written NR, and soon. If they manage that in the next couple of weeks, there is still hope.
The alternative is, unfortunately, the end. Many here and on CEO.ca insist SONA is not just a one trick pony, but this is completely untrue. SONA is the dictionary definition of one. The GNR technology is many decades old, and unlikely to be commercialized for anything other than the COVID test. Being CTAB-free is only valuable for in-vivo applications, of which there are none for GNRs. Good luck to all